Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03533608 · ClinicalTrials.gov registry record · NA
Optimizing Treatment Response in VA Specialized Intensive/Inpatient PTSD Programs
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT03533608: Completed NA study, sponsored by VA Office of Research and Development.
NCT03533608 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 39 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03533608, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
Prolonged Exposure therapy (PE) is a first-line treatment for posttraumatic stress disorder; however few VA patients receive this treatment. One of the barriers to PE receipt is that this treatment is only available in an individual (one-on-one) format, whereas many VA mental health clinics provide the majority of their psychotherapy services in group format. In particular, PTSD residential rehabilitation programs (RRTPs) offer most programming in group format. Thus, the current study was designed to pilot test a group format of PE in RRTPs.
Interventions
- BEHAVIORAL Group PE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2020-03-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03533608
The ClinicalTrials.gov registry entry for NCT03533608 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Group PE is the first listed.
NCT03533608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03533608 about?
NCT03533608 is a clinical study titled "Optimizing Treatment Response in VA Specialized Intensive/Inpatient PTSD Programs". Prolonged Exposure therapy (PE) is a first-line treatment for posttraumatic stress disorder; however few VA patients receive this treatment. One of the barriers to PE receipt is that this treatment is only available in an individual (one-on-one) format, whereas many VA mental health clinics provide ...
What is the current status of trial NCT03533608?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2018-06-01. Estimated completion is 2020-03-15.
What interventions are being tested in trial NCT03533608?
The interventions under investigation include: Group PE (BEHAVIORAL).
Who is sponsoring clinical trial NCT03533608?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.